oxazolidin-2-one has been researched along with clarithromycin in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (32.00) | 29.6817 |
2010's | 16 (64.00) | 24.3611 |
2020's | 1 (4.00) | 2.80 |
Authors | Studies |
---|---|
Apfalter, P; Hirschl, AM; Makristathis, A; Rotter, ML; Wimmer, M | 1 |
Gikas, A; Psaroulaki, A; Scoulica, E; Spyridaki, I; Tselentis, Y | 1 |
Binstock, P; Keating, M; Kontoyiannis, DP; Nannini, EC; Samonis, G | 1 |
Kyle, SD; Porter, WM | 1 |
Borrás, R; de Julián-Ortiz, JV; Domínguez, V; Gálvez, J; García-García, A; Guna, R; Muñoz, C | 1 |
Jackson, MA; Selvarangan, R; Sharma, M; Thorell, EA; Woods, GM | 1 |
Tam, WO; Tse, TF; Wong, PC; Yam, WC; Yew, WW; Yuen, KY | 1 |
Fierlbeck, G; Hoetzenecker, W; Kempf, VA; Klingel, K; Metzler, G; Schanz, S; Ulmer, A | 1 |
Alffenaar, JW; Bolhuis, MS; Kosterink, JG; Uges, DR; van Altena, R; van der Werf, TS | 1 |
Lin, YH; Liu, TC | 1 |
Andries, K; Bantubani, N; De Marez, T; Diacon, AH; Donald, PR; Grobusch, M; Lounis, N; Mahanyele, R; McNeeley, DF; Meyvisch, P; Narasimooloo, R; Patientia, RF; Pym, A; van Heeswijk, R | 1 |
Borole, AJ; Chilgar, RM; D'Silva, JA; Thomas, M | 1 |
Alffenaar, JW; Bolhuis, MS; de Lange, WC; Kosterink, JG; Uges, DR; van Altena, R; van der Werf, TS; van Soolingen, D | 1 |
Alffenaar, JW; Bolhuis, MS; de Lange, WC; Greijdanus, B; Kosterink, JG; Uges, DR; van Altena, R; van der Werf, TS; van Hateren, K | 1 |
Hayashi, S; Iwamoto, T; Okada, M; Saito, H; Suzuki, K; Tomita, M; Tsuyuguchi, K; Yoshida, S | 1 |
Gui, J; Hong, CY; Li, JL; Liang, J; Wang, F | 1 |
Migliori, GB; Peloquin, CA; Sotgiu, G; Srivastava, S | 1 |
Alffenaar, JW; Bolhuis, MS; Kosterink, JG; van der Laan, T; van der Werf, TS; van Soolingen, D | 1 |
Alves, SH; Loreto, ES; Pilotto, MB; Santurio, JM; Tondolo, JS | 1 |
Butler-Laporte, G; Menzies, D; Winters, N | 1 |
Kern, WV; Schuster, S; Vavra, M | 1 |
Arthur, M; Compain, F; Dorchène, D; Dubée, V; Gaillard, JL; Herrmann, JL; Heym, B; Soroka, D | 1 |
Alves, SH; Loreto, ES; Oliveira, DC; Santurio, JM; Tondolo, JSM | 1 |
Almeida, DV; Converse, PJ; Grosset, JH; Lee, J; Li, SY; Nuermberger, EL; Omansen, TF | 1 |
Jhun, BW; Kim, LH; Kim, SY; Lee, JM; Lee, W; Shin, SJ | 1 |
1 review(s) available for oxazolidin-2-one and clarithromycin
Article | Year |
---|---|
Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment.
Topics: Amoxicillin; Antitubercular Agents; Azithromycin; Cilastatin; Clarithromycin; Clavulanic Acid; HIV Infections; Humans; Imipenem; Isoxazoles; Macrolides; Meropenem; Mycobacterium tuberculosis; Oxazolidinones; Randomized Controlled Trials as Topic; Thienamycins; Thioridazine; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization | 2015 |
3 trial(s) available for oxazolidin-2-one and clarithromycin
Article | Year |
---|---|
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.
Topics: Antitubercular Agents; Clarithromycin; Cycloserine; Dapsone; Diarylquinolines; Erythromycin; Female; Humans; Isoxazoles; Male; Ofloxacin; Oxazolidinones; Quinolines; Tuberculosis, Multidrug-Resistant | 2012 |
Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients.
Topics: Acetamides; Adult; Aged; Antitubercular Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Drug Interactions; Drug Monitoring; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Prospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult | 2013 |
Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosis.
Topics: Acetamides; Adult; Antitubercular Agents; Area Under Curve; Clarithromycin; Confidence Intervals; Drug Monitoring; Female; Humans; Linezolid; Male; Metabolic Clearance Rate; Oxazolidinones; Prospective Studies; Saliva; Tuberculosis, Multidrug-Resistant; Young Adult | 2013 |
21 other study(ies) available for oxazolidin-2-one and clarithromycin
Article | Year |
---|---|
In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori.
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Helicobacter pylori; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Penicillins | 2000 |
In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Clarithromycin; Coxiella burnetii; Doxycycline; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Q Fever; Vero Cells | 2001 |
Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Fluoroquinolones; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Linezolid; Male; Mefloquine; Middle Aged; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Oxazolidinones; Quinolines | 2002 |
Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Forearm; Humans; Linezolid; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Opportunistic Infections; Oxazolidinones; Skin Diseases, Bacterial | 2004 |
In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Clarithromycin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium kansasii; Oxazolidinones; Quinolines | 2005 |
Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients.
Topics: Acetamides; Adolescent; Amikacin; Anemia, Sickle Cell; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Linezolid; Microbial Sensitivity Tests; Mycobacterium fortuitum; Mycobacterium Infections; Oxazolidinones; Treatment Outcome | 2006 |
Pacemaker infections due to rapidly growing mycobacteria: further experience.
Topics: Acetamides; Aged; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Humans; Linezolid; Mycobacterium Infections; Ofloxacin; Oxazolidinones; Pacemaker, Artificial; Prosthesis-Related Infections; Surgical Wound Infection | 2007 |
Dissemination of a localized cutaneous infection with Mycobacterium chelonae under immunosuppressive treatment.
Topics: Acetamides; Anti-Infective Agents; Clarithromycin; Diagnosis, Differential; Female; Humans; Immunocompromised Host; Linezolid; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Skin Ulcer | 2007 |
Clarithromycin significantly increases linezolid serum concentrations.
Topics: Acetamides; Adult; Chromatography, Liquid; Clarithromycin; Clofazimine; Cycloserine; Drug Interactions; Humans; Linezolid; Male; Oxazolidinones; Tandem Mass Spectrometry; Tuberculosis, Pulmonary | 2010 |
Mycobacterium chelonae infection involving the auricle.
Topics: Acetamides; Adult; Anti-Infective Agents; Clarithromycin; Ear Auricle; Humans; Linezolid; Lymph Nodes; Lymphadenitis; Male; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Neck; Oxazolidinones; Skin Diseases, Bacterial; Treatment Outcome | 2012 |
Periprosthetic atypical mycobacterial infection in breast implants: a new kid on the block!
Topics: Acetamides; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Breast Implants; Clarithromycin; Female; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Mammaplasty; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Reoperation | 2013 |
Further isolation of Mycobacterium abscessus subsp. abscessus and subsp. bolletii in different regions of Japan and susceptibility of these isolates to antimicrobial agents.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chaperonin 60; Clarithromycin; DNA-Directed RNA Polymerases; DNA, Intergenic; Drug Resistance, Bacterial; Female; Genotype; Humans; Japan; Linezolid; Male; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Oxazolidinones; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2013 |
[Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Topics: Acetamides; Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Culture Media; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Oxazolidinones; Sensitivity and Specificity; Tobramycin | 2013 |
Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?
Topics: Acetamides; Antitubercular Agents; Clarithromycin; Female; Humans; Linezolid; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2013 |
In vitro synergy between linezolid and clarithromycin against Mycobacterium tuberculosis.
Topics: Acetamides; Anti-Bacterial Agents; Biological Specimen Banks; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Multidrug-Resistant | 2014 |
New insights into the in vitro susceptibility of Pythium insidiosum.
Topics: Acetamides; Anti-Bacterial Agents; Antifungal Agents; Azithromycin; Clarithromycin; Doxycycline; Linezolid; Microbial Sensitivity Tests; Minocycline; Mupirocin; Oxazolidinones; Pythium; Tigecycline | 2014 |
Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Oxazolidinones; Tetracyclines | 2016 |
In vitro activity of tedizolid against the Mycobacterium abscessus complex.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Tetrazoles; Tigecycline | 2018 |
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bridged Bicyclo Compounds, Heterocyclic; Clarithromycin; Diterpenes; Humans; Josamycin; Linezolid; Macrolides; Oomycetes; Oxazolidinones; Phosphorylcholine; Pleuromutilins; Polycyclic Compounds; Pythiosis; Pythium | 2018 |
Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer.
Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Clarithromycin; Disease Models, Animal; Female; Linezolid; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Oxazolidinones; Rifampin; Tetrazoles | 2019 |
Intracellular and in vivo activities of oxazolidinone drugs against Mycobacterium avium complex infection.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Humans; Lung Diseases; Macrolides; Mice; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Oxazolidinones | 2023 |